Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, lomustine capsules declared by the company as a domestic agent obtained a “Drug Registration Certificate” issued by the State Drug Administration. Lomustine capsules are suitable for children and adults with primary malignant brain tumors after surgery and/or radiation therapy.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.